2014
DOI: 10.1186/1749-8090-9-14
|View full text |Cite
|
Sign up to set email alerts
|

A rare case of primary cardiac B cell lymphoma

Abstract: Primary cardiac lymphomas represent an extremely rare entity of extranodal lymphomas and should be distinguished from secondary cardiac involvement of disseminated lymphomas belonging to the non-Hodgkin’s classification of blood cancers. Only 90 cases have been reported in literature. Presentation of cardiac lymphomas on imaging studies may not be unambiguous since they potentially mimic other cardiac neoplasms including myxomas, angiosarcoma or rhadomyomas and therefore require multimodality cardiac imaging, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
38
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(39 citation statements)
references
References 5 publications
0
38
0
1
Order By: Relevance
“…To our knowledge, only 23 cases of PCL in immunocompetent patients have been reported to date (Table I). [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] According to these reports, no patient presented with noncardiac lymphomatous localization, but, as in our patient, it was impossible to absolutely exclude noncardiac involvement in the absence of autopsic investiga- Nine of these patients were treated with surgical excision followed by chemotherapy, and 5 of them survived at least 6 months after treatment. No evidence exists concerning the necessity of surgery as an adjunct to chemotherapy in PCL; moreover, in those 9 cases surgery was the final diagnostic step, along with excision as treatment.…”
Section: Discussionmentioning
confidence: 93%
“…To our knowledge, only 23 cases of PCL in immunocompetent patients have been reported to date (Table I). [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] According to these reports, no patient presented with noncardiac lymphomatous localization, but, as in our patient, it was impossible to absolutely exclude noncardiac involvement in the absence of autopsic investiga- Nine of these patients were treated with surgical excision followed by chemotherapy, and 5 of them survived at least 6 months after treatment. No evidence exists concerning the necessity of surgery as an adjunct to chemotherapy in PCL; moreover, in those 9 cases surgery was the final diagnostic step, along with excision as treatment.…”
Section: Discussionmentioning
confidence: 93%
“…Therefore, diagnosis of PCL requires further imaging with transoesophageal echocardiography, cardiac MRI, CT and positron emission tomography scanning, leading to endomyocardial biopsy 9. Only when this histological (or, more rarely, cytological via pericardial fluid) diagnosis is obtained, can the patient be considered for chemotherapy or surgery.…”
Section: Discussionmentioning
confidence: 99%
“…Dissemination can occur by lymphatic, bloodstream or contiguous extension [2,17]. Imagistic examination (ultrasonography, CT, PET/CT) has a significant role in establishing the degree of myocardial and pericardic infiltration, extracardiac dissemination and heart function [8].…”
Section: Discussionmentioning
confidence: 99%
“…Disadvantages of TTE include a potentially restricted field of view and underestimation of tumor extension. Cardiac computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) are further required to fully characterize tumor size and density, myocardial infiltration and metabolic activity [4,8,9].…”
Section: Introductionmentioning
confidence: 99%